(Q45946995)

18 December 2017

title

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. (English)

1 reference

18 December 2017

author

Franco Muggia

14

1 reference

18 December 2017

Lynn G Feun

3

object named as

Lynn Feun

1 reference

18 December 2017

author name string

Jennifer Wu

1

1 reference

18 December 2017

Charles Henderson

2

1 reference

18 December 2017

Peter Van Veldhuizen

4

1 reference

18 December 2017

Philip Gold

5

1 reference

18 December 2017

Hui Zheng

6

1 reference

18 December 2017

Theresa Ryan

7

1 reference

18 December 2017

Lawrence S Blaszkowsky

8

1 reference

18 December 2017

Haobin Chen

9

1 reference

18 December 2017

Max Costa

10

1 reference

18 December 2017

Barry Rosenzweig

11

1 reference

18 December 2017

MaryLynn Nierodzik

12

1 reference

18 December 2017

Howard Hochster

13

1 reference

18 December 2017

Giovanni Abbadessa

15

1 reference

18 December 2017

Jonathan Lewis

16

1 reference

18 December 2017

Andrew X Zhu

17

1 reference

18 December 2017

publication date

30 June 2009

1 reference

18 December 2017

Investigational New Drugs

published in

1 reference

18 December 2017

volume

28

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

670-676

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s10637-009-9286-9

exact match

0 references

cites work

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

Effect of arsenic trioxide on human hepatocarcinoma in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

Chemical and clinical development of darinaparsin, a novel organic arsenic derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9286-9

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

12 December 2020

Long term low-dose arsenic exposure induces loss of DNA methylation

1 reference

12 December 2020

Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice

1 reference

12 December 2020

Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization

1 reference

12 December 2020

Antitumor effect of arsenic trioxide in murine xenograft model

1 reference

12 December 2020

Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis

1 reference

12 December 2020

[Arsenic trioxide in the treatment of advanced primary liver and gallbladder cancer]

1 reference

12 December 2020

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

12 December 2020

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Effects of HBV X gene and arsenic trioxide on the expression of p53 in cultured HepG2 cells.

1 reference

12 December 2020

Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial

1 reference

12 December 2020

Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo

1 reference

12 December 2020

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

1 reference

12 December 2020

A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines

1 reference

12 December 2020

10.1007/S10637-009-9286-9

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1001960219

0 references

1 reference

18 December 2017